General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

Description

In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.

Conditions

Type 1 Diabetes, Celiac Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.

Sanford Population Level Estimation of Type 1 Diabetes Risk GEnes in Children

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

Condition
Type 1 Diabetes
Intervention / Treatment

-

Contacts and Locations

Bemidji

Sanford Bemidji Region Clinics, Bemidji, Minnesota, United States, 56601

Bismarck

Sanford Bismarck Region Clinics, Bismarck, North Dakota, United States, 58501

Fargo

Sanford Fargo Region Clinics, Fargo, North Dakota, United States, 58112

Sioux Falls

Sanford Sioux Falls Region Clinics, Sioux Falls, South Dakota, United States, 57105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Newborn Entry: Viable, term infants, defined as 36 weeks gestation by either dates or ultrasound who are born to pregnant women, 18 years or older, who are willing and able to provide informed consent (IC) prior to the onset of active labor. Who are born at a Sanford Health Hospital and plan to have routine well-child care at a Sanford Clinic
  • * Pediatric Entry: Children less than 6 years of age who receive their routine care at a Sanford facility and whose parents are able to provide IC.
  • * Adolescent Entry: Children, ages 9-16 years old, who receive their routine care at a Sanford facility and whose parents are able to provide IC.
  • * Siblings of children known to have T1D-relevant antibodies; ages 6 to 17 years old who receive care at a Sanford clinic
  • * Have an active MyChart account (with proxy access).
  • * Subject is in the opinion of the investigator, unable to comply with the requirements of the study protocol.
  • * Children known to have T1D

Ages Eligible for Study

0 Minutes to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Sanford Health,

Kurt Griffin, PhD, MD, PRINCIPAL_INVESTIGATOR, Sanford Research

Study Record Dates

2031-03